Community-acquired pneumonia (CAP) still remains one of the most important causes of morbidity and mortality. Improving the care of patients with CAP has been the focus of many different organizations, and several guidelines have been published in the United States and Europe. When the patients ...
Objective To observe and analyze the clinic situation and the therapeutic efficacy of community acquired pneumonia (CAP). Methods The symptoms, signs, X-ray character and therapeutic efficacy of 308 patients with CAP were analyzed retrospectively. Results Among 308 patients, the pathogens were isolated...
Background: The benefit of corticosteroids in community-acquired pneumonia (CAP) remains controversial.We did a meta-analysis to include all the randomized controlled trials (RCTs) which used corticosteroids as adjunctive therapy, to examine the benefits and risks of corticosteroids in the treatment of...
Is Azithromycin the First-Choice Macrolide for Treatment of Community-Acquired Pneumonia? Combination treatment with a β-lactam plus a macrolide may improve the outcome for elderly patients with community-acquired pneumonia (CAP). The prognoses... F Sánchez,J Mensa,JA Martínez,... - 《Clinical...
Treatment guidelines for community-acquired pneumonia (CAP) generally include use of a macrolide, a fluoroquinolone, or doxycycline, although there is some debate concerning the use of a fluoroquinolone. The efficacy and tolerability of ... AR Salkind,PG Cuddy,JW Foxworth - Interscience Conference ...
Community-acquired pneumonia in the elderly: Spanish multicentre study Community-acquired pneumonia (CAP) in the elderly has increased as a consequence of an overall increase of the elderly population. A controversy about the ... R Zalacain,A Torres,R Celis,... - 《European Respiratory Journal》...
In the UK, older people are particularly prone to developing community acquired pneumonia. The most common pathogen is the bacterium Streptococcus pneumoniae. In the environment, S. pnumoniae is a robust microbe that can adapt and survive in hostile conditions and in the human body. Antibiotic th...
The article discusses the benefits of steroid use as an adjunctive therapy for patients diagnosed with community-acquired pneumonia (CAP). Information provided include how steroid can improve outcomes CAP treatment, such as reduced hospital length of stay, decreased time to clinical stability, and lowe...
Objectives: Ceftaroline fosamil (CPT-F), a cephalosporin with broad-spectrum in vitro activity, is approved by the European Medicines Agency for the treatment of complicated skin and soft tissue infections and community-acquired pneumonia (CAP) and is approved in the US for similar indications. CAP...
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis. 2003;37(6):752-760.PubMedGoogle ScholarCrossref 28. File TM Jr, Mandell LA, Tillotson G, Kostov K, Georgiev O. Gemifloxacin once daily for 5 days versus 7 days for the ...